It has been a mixed year for Mineralys Therapeutics, Inc. insiders: $8.8 million bought by one person and $89.5 million sold by eight, so more selling than buying overall.
The largest purchase came from Shah Rajeev M. (Director), about $7.4 million.
Big money check: 226 institutions held MLYS as of Q2 2026, and more funds bought than sold. Looking at the quarterly pattern: 4 quarters in a row of net selling by insiders. Insiders bought in 3 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Congleton Jon | CEO | Sell | 75,000 | $25.46 | $1.9M | SEC |
| Sep 24, 2026 | Slingsby Brian Taylor | Director | Sell | 104,320 | $28.81 | $3.0M | SEC |
| Sep 22, 2026 | Warren Eric | Executive Officer | Sell | 7,438 | $28.12 | $209K | SEC |
| Sep 17, 2026 | Karydas Daphne | Director | Sell | 3,000 | $28.58 | $86K | SEC |
| Aug 25, 2026 | Warren Eric | Executive Officer | Sell | 7,437 | $25.98 | $193K | SEC |
| Aug 12, 2026 | Rodman David Malcom | Executive Officer | Sell | 2,170 | $27.09 | $59K | SEC |
| Jul 23, 2026 | Warren Eric | Executive Officer | Sell | 7,438 | $26.87 | $200K | SEC |
| Jul 20, 2026 | Rodman David Malcom | Executive Officer | Sell | 416 | $26.53 | $11K | SEC |
| Jul 15, 2026 | Congleton Jon | CEO | Sell | 10,700 | $27.24 | $291K | SEC |
| Jul 15, 2026 | Rodman David Malcom | Executive Officer | Sell | 14,058 | $27.58 | $388K | SEC |
| Jul 15, 2026 | Rodman David Malcom | Executive Officer | Sell | 6,349 | $26.61 | $169K | SEC |
| Jul 10, 2026 | Rodman David Malcom | Executive Officer | Sell | 2,171 | $30.30 | $66K | SEC |
| Jun 30, 2026 | Congleton Jon | CEO | Sell | 17,000 | $26.82 | $456K | SEC |
| Jun 30, 2026 | Congleton Jon | CEO | Sell | 58,000 | $25.94 | $1.5M | SEC |
| Jun 30, 2026 | Warren Eric | Executive Officer | Sell | 104,124 | $25.90 | $2.7M | SEC |
In the last 12 months Mineralys Therapeutics, Inc. insiders made open-market purchases worth about $8.8 million and sales worth about $89.5 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in MLYS was filed on 2026-10-02.
226 investment managers reported holding MLYS in SEC Form 13F filings for Q2 2026.
No congressional trades in MLYS were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).